Biopharmaceutical research companies are conducting or have conducted nearly 1,300 clinical trials of new medicines in collaboration with the state’s university medical schools, clinical research centers and hospitals (1999 to present).
Of the nearly 1,300 clinical trials, 676 have targeted the nation’s six most debilitating chronic diseases— asthma/allergy, cancer, diabetes, heart disease, mental illnesses and stroke.
"Iowans may not realize that clinical trials performed right here in Iowa play a very important role in drug development. The ICCR network allows patients to participate actively in clinical trials, which contributes to the development of new drugs and may benefit all Iowans." --Dr. John M. Weiler CompleWare